CHO Pharma Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Chung-Yi Wu
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 2.2yrs |
CEO ownership | n/a |
Management average tenure | no data |
Board average tenure | 2.9yrs |
CEO
Chung-Yi Wu
2.2yrs
Tenure
Dr. Chung-Yi Wu serves as President at CHO Pharma, Inc. since March 2022 and serves as its General Manager & Director since 2022 and also serves as its Chief Executive Officer. He served as Executive Vice...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 2.3yrs | no data | no data | |
Director | 2.3yrs | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Chairman of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Chairman | no data | no data | no data | |
Independent Director | 4.9yrs | no data | no data | |
Member of Scientific Advisory Board | 2.9yrs | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | 3.3yrs | no data | no data | |
Independent Director | no data | no data | no data |
2.9yrs
Average Tenure
Experienced Board: 6586's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.